IPOP students and researchers conduct leading-edge research in four core areas.
The primary goal of this core is to provide methodologically-sound research informing pharmaceutical regulatory policy. Current active research in this area includes:
Prescription Drug Monitoring Programs (PDMP): Research analyzing the impact and effectiveness of PDMPs in reducing controlled substance abuse and diversion, while simultaneously promoting responsible practices in controlled substance prescribing and use.
Pseudoephedrine (PSE) Sales: Analysis of the appropriate policy response to the use of PSE in the production of methamphetamine for the illicit purposes of diversion and abuse.
National Association of State Controlled Substances Authorities (NASCSA) white paper and webinar: Impact of State Laws Regulating Pseudoephedrine on Methamphetamine Tracking & Abuse (http://www.nascsa.org/)
Medical Marijuana: Analysis of the regulatory policies promoting the safe and effective use of marijuana for legitimate medical purposes.
Pain Clinic Regulation: In Kentucky and 6 other states, laws have been passed to regulate the formation and function of pain clinics in an effort to reduce the diversion and abuse of controlled substances through their operation. Research to analyze the effectiveness of these laws will help to inform what other states can learn as they develop their own policies to address these same issues in coming years.
The primary goal of this core is to develop, maintain, and make effective use of biomedical data, information, and knowledge in support of the translation of science into health and pharmaceutical policy and outcomes.
- Center for Clinical and Translational Science (CCTS)
IPOP serves as the operational research core for the CCTS informatics group, and is responsible for developing, maintaining, and facilitating research utilizing retrospective data and informatics tools, including:
- UK HealthCare Clinical Data Warehouse (CDW)
- Large Commercially Insured Data Mart
- REDCap (Research Electronic Data Capture)
- I2b2 (Informatics for Integrating Biology and the Bedside)
Department for Behavioral Health and Developmental and Intellectual Disabilities (DBHDID)
IPOP developed, maintains, and analyzes monthly performance and outcome measurement data from the Kentucky public mental health system.
Kentucky Diabetes and Obesity Collaborative (KDOC)
KDOC represents a transformative initiative to develop a novel and sustainable research infrastructure designed for the long-term goals of mitigating the public health burdens of obesity and diabetes in a rural, medically-underserved population and generating new knowledge applicable to similar populations.
The primary goal of this core is to provide support for the data analysis, reporting, and outcomes needs of specific project-based research.
IPOP provides program evaluation services to the following groups:
- University of Kentucky Human Resources
- Kentucky Transitions or Money Follows the Person (MFP)
The purpose of the grant is to facilitate transition of, and to provide sustainable community-based services to, individuals who choose to move from Medicaid-funded long-term care settings (ICFs/MR and nursing facilities) into the community.
- Medicaid Managed Care (MMC)
The Foundation for a Healthy Kentucky contracted with the Urban Institute in partnership with IPOP researchers to study this transition of Kentucky's Medicaid program from fee-for-service to managed care. Specifically, the project will focus on assessing its impact on access, cost and quality for this substantial portion of the population (nearly 800,000 Kentuckians).
- Kentuckiana Health Collaborative (KHC)
KHC issues an annual Consolidated Measurement Report on health care delivery in the 7- county region surrounding Louisville. These reports are compiled by IPOP analysts and include HEDIS and HEDIS-derived measures of treatment quality for several chronic and acute conditions. In addition to creating reports for individual physicians, IPOP analysts create aggregate reports for each participating health plan, as well as an aggregate report for county-level data. The aggregate reports can be seen on the KHC website.
The primary goal of this core is to provide methodologically-sound pharmaceutical outcomes research informing providers and patients on safe and effective treatments that will translate to improved health outcomes.
Current active research in this area includes:
- Medication use and effectiveness in the elderly, currently with an emphasis on those in VA and nursing homes
- Comparative safety and effectiveness of antiretroviral medications, with a focus on Medicaid populations and EMR use
- Development of pharmacoepidemiology methodology with a focus on validation